Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2015, Volume 136, Issue 4, pp. 1095 - 1097.e3
 [...]we compared sensitization patterns found using CRD with results of serum-IgE CAP testing and skin prick test (SPT). [...]to validate CRD results,...
Allergy and Immunology | ADULTS | IMMUNOLOGY | ALLERGY | CHILDREN | Prospective Studies | Eosinophilic Esophagitis - diet therapy | Humans | Middle Aged | Adolescent | Allergens - chemistry | Eosinophilic Esophagitis - blood | Adult | Female | Male | Child | Protein Array Analysis - methods | Allergy | Allergens | Care and treatment | Allergic reaction | Analysis | Food allergies | Nuts | Diet | Endoscopy | Patients | Milk | Rice
Allergy and Immunology | ADULTS | IMMUNOLOGY | ALLERGY | CHILDREN | Prospective Studies | Eosinophilic Esophagitis - diet therapy | Humans | Middle Aged | Adolescent | Allergens - chemistry | Eosinophilic Esophagitis - blood | Adult | Female | Male | Child | Protein Array Analysis - methods | Allergy | Allergens | Care and treatment | Allergic reaction | Analysis | Food allergies | Nuts | Diet | Endoscopy | Patients | Milk | Rice
Journal Article
Gut, ISSN 0017-5749, 12/2013, Volume 62, Issue 12, pp. 1676 - 1683
Objective The value of surveillance for patients with Barrett's oesophagus (BO) is under discussion given the overall low incidence of neoplastic progression...
POPULATION | Barrett's Carcinoma | ADENOCARCINOMA | OVEREXPRESSION | LOW-GRADE DYSPLASIA | Barrett's Metaplasia | METAPLASIA | COHORT | ACCUMULATION | Barrett's Oesophagus | GASTROENTEROLOGY & HEPATOLOGY | MALIGNANT PROGRESSION | DISEASE PROGRESSION | IMMUNOHISTOCHEMISTRY | Esophageal Neoplasms - etiology | Barrett Esophagus - metabolism | Barrett Esophagus - complications | Adenocarcinoma - pathology | Prospective Studies | Adenocarcinoma - etiology | Humans | Middle Aged | Risk Factors | Tumor Suppressor Protein p53 - metabolism | Esophagus - metabolism | Male | Precancerous Conditions - metabolism | Case-Control Studies | Esophageal Neoplasms - pathology | Esophagus - pathology | Adenocarcinoma - metabolism | Barrett Esophagus - pathology | Esophageal Neoplasms - metabolism | Female | Precancerous Conditions - pathology | Aged | Immunohistochemistry | Complications and side effects | Usage | Phosphoproteins | Barrett's esophagus | Influence | Development and progression | Risk factors | Tumors | Proteins | Studies | Surveillance | Biopsy | Biomarkers | Mutation | Endoscopy
POPULATION | Barrett's Carcinoma | ADENOCARCINOMA | OVEREXPRESSION | LOW-GRADE DYSPLASIA | Barrett's Metaplasia | METAPLASIA | COHORT | ACCUMULATION | Barrett's Oesophagus | GASTROENTEROLOGY & HEPATOLOGY | MALIGNANT PROGRESSION | DISEASE PROGRESSION | IMMUNOHISTOCHEMISTRY | Esophageal Neoplasms - etiology | Barrett Esophagus - metabolism | Barrett Esophagus - complications | Adenocarcinoma - pathology | Prospective Studies | Adenocarcinoma - etiology | Humans | Middle Aged | Risk Factors | Tumor Suppressor Protein p53 - metabolism | Esophagus - metabolism | Male | Precancerous Conditions - metabolism | Case-Control Studies | Esophageal Neoplasms - pathology | Esophagus - pathology | Adenocarcinoma - metabolism | Barrett Esophagus - pathology | Esophageal Neoplasms - metabolism | Female | Precancerous Conditions - pathology | Aged | Immunohistochemistry | Complications and side effects | Usage | Phosphoproteins | Barrett's esophagus | Influence | Development and progression | Risk factors | Tumors | Proteins | Studies | Surveillance | Biopsy | Biomarkers | Mutation | Endoscopy
Journal Article
Hepatology (Baltimore, Md.), ISSN 0270-9139, 2013, Volume 57, Issue 1, pp. 183 - 194
The mechanisms that enable liver cancer to escape elimination by the immune system remain unclear, but their elucidation may provide novel therapeutic...
HEPATOCELLULAR-CARCINOMA | CONTRIBUTE | VIRUS-INFECTION | DENDRITIC CELLS | MICROENVIRONMENT | COLORECTAL-CANCER | TOLERANCE | RECEPTOR | LIGAND | SUPPRESSION | GASTROENTEROLOGY & HEPATOLOGY | Cell Proliferation | Lymphocyte Activation | Humans | Middle Aged | Glucocorticoid-Induced TNFR-Related Protein - metabolism | Liver Neoplasms - drug therapy | Liver Neoplasms - immunology | Male | Tumor Necrosis Factors - therapeutic use | Carcinoma, Hepatocellular - drug therapy | Immunotherapy | Female | Aged | Carcinoma, Hepatocellular - immunology | Inducible T-Cell Co-Stimulator Protein - metabolism | Colorectal Neoplasms - pathology | Liver Neoplasms - secondary | T-Lymphocytes, Regulatory - physiology | Liver cancer | Medical research | Liver | Cancer | Tumors
HEPATOCELLULAR-CARCINOMA | CONTRIBUTE | VIRUS-INFECTION | DENDRITIC CELLS | MICROENVIRONMENT | COLORECTAL-CANCER | TOLERANCE | RECEPTOR | LIGAND | SUPPRESSION | GASTROENTEROLOGY & HEPATOLOGY | Cell Proliferation | Lymphocyte Activation | Humans | Middle Aged | Glucocorticoid-Induced TNFR-Related Protein - metabolism | Liver Neoplasms - drug therapy | Liver Neoplasms - immunology | Male | Tumor Necrosis Factors - therapeutic use | Carcinoma, Hepatocellular - drug therapy | Immunotherapy | Female | Aged | Carcinoma, Hepatocellular - immunology | Inducible T-Cell Co-Stimulator Protein - metabolism | Colorectal Neoplasms - pathology | Liver Neoplasms - secondary | T-Lymphocytes, Regulatory - physiology | Liver cancer | Medical research | Liver | Cancer | Tumors
Journal Article
European heart journal, ISSN 0195-668X, 2012, Volume 33, Issue 9, pp. 1142 - 1149
A randomized, double-blind, placebo-controlled study was conducted to investigate the safety and efficacy of mipomersen, an apolipoprotein B-100 (apoB)...
Antisense oligonucleotides | Lipoproteins | Hepatic steatosis | Hypercholesterolaemia | Statin intolerance | FAMILIAL HYPERCHOLESTEROLEMIA | CARDIAC & CARDIOVASCULAR SYSTEMS | FATTY LIVER-DISEASE | 20 MG | LDL CHOLESTEROL | HEART-DISEASE | MAGNETIC-RESONANCE-SPECTROSCOPY | ANTISENSE INHIBITOR | CORONARY ATHEROSCLEROSIS | INSULIN-RESISTANCE | Double-Blind Method | Oligonucleotides - therapeutic use | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Risk Factors | Male | Treatment Outcome | Cardiovascular Diseases - enzymology | Hypercholesterolemia - drug therapy | Anticholesteremic Agents - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Apolipoprotein B-100 - antagonists & inhibitors | Hypercholesterolemia - enzymology | Cholesterol, LDL - metabolism | Adult | Female | Aged | Alanine Transaminase - metabolism | Clinical Research
Antisense oligonucleotides | Lipoproteins | Hepatic steatosis | Hypercholesterolaemia | Statin intolerance | FAMILIAL HYPERCHOLESTEROLEMIA | CARDIAC & CARDIOVASCULAR SYSTEMS | FATTY LIVER-DISEASE | 20 MG | LDL CHOLESTEROL | HEART-DISEASE | MAGNETIC-RESONANCE-SPECTROSCOPY | ANTISENSE INHIBITOR | CORONARY ATHEROSCLEROSIS | INSULIN-RESISTANCE | Double-Blind Method | Oligonucleotides - therapeutic use | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Risk Factors | Male | Treatment Outcome | Cardiovascular Diseases - enzymology | Hypercholesterolemia - drug therapy | Anticholesteremic Agents - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Apolipoprotein B-100 - antagonists & inhibitors | Hypercholesterolemia - enzymology | Cholesterol, LDL - metabolism | Adult | Female | Aged | Alanine Transaminase - metabolism | Clinical Research
Journal Article
Hepatology (Baltimore, Md.), ISSN 0270-9139, 2016, Volume 64, Issue 2, pp. 501 - 507
Immunoglobulin G4 (IgG4)-related disease (IgG4-RD) of the biliary tree and pancreas is difficult to distinguish from sclerosing cholangitis and...
Diagnosis, Differential | Prospective Studies | Immunoglobulin G - blood | Humans | Middle Aged | Aged, 80 and over | Bile Duct Diseases - diagnosis | Female | Male | Aged | Bile Duct Diseases - immunology | Case-Control Studies | Immunoglobulins | Liver | Autoimmune, Cholestatic and Biliary Disease
Diagnosis, Differential | Prospective Studies | Immunoglobulin G - blood | Humans | Middle Aged | Aged, 80 and over | Bile Duct Diseases - diagnosis | Female | Male | Aged | Bile Duct Diseases - immunology | Case-Control Studies | Immunoglobulins | Liver | Autoimmune, Cholestatic and Biliary Disease
Journal Article
Hepatology (Baltimore, Md.), ISSN 0270-9139, 2013, Volume 57, Issue 6, pp. 2390 - 2398
Immunoglobulin G4 (IgG4)-associated cholangitis (IAC) is a manifestation of the recently discovered idiopathic IgG4-related disease. The majority of patients...
G4-ASSOCIATED CHOLANGITIS | SCLEROSING CHOLANGITIS | GASTROENTEROLOGY & HEPATOLOGY | AUTOIMMUNE PANCREATITIS | SERUM IGG4 | Duodenum - immunology | Prospective Studies | Humans | Immunoglobulin G - chemistry | Middle Aged | Immunoglobulin Heavy Chains - chemistry | Male | Cholangitis - immunology | Cholangitis - blood | Case-Control Studies | Receptors, Antigen, B-Cell - chemistry | Adult | Female | Aged | Hepatology | Immunology | Immune system
G4-ASSOCIATED CHOLANGITIS | SCLEROSING CHOLANGITIS | GASTROENTEROLOGY & HEPATOLOGY | AUTOIMMUNE PANCREATITIS | SERUM IGG4 | Duodenum - immunology | Prospective Studies | Humans | Immunoglobulin G - chemistry | Middle Aged | Immunoglobulin Heavy Chains - chemistry | Male | Cholangitis - immunology | Cholangitis - blood | Case-Control Studies | Receptors, Antigen, B-Cell - chemistry | Adult | Female | Aged | Hepatology | Immunology | Immune system
Journal Article
Gastrointestinal Endoscopy, ISSN 0016-5107, 2017, Volume 85, Issue 5, pp. 1025 - 1031
Background and Aims Currently, 3 guidelines are available for the management of pancreatic cysts. These guidelines vary in their indication for resection of...
Gastroenterology and Hepatology | PAPILLARY MUCINOUS NEOPLASMS | DIAGNOSIS | MALIGNANCY | PREVALENCE | GASTROENTEROLOGY & HEPATOLOGY | LESIONS | INTERNATIONAL CONSENSUS GUIDELINES | Neuroendocrine Tumors - pathology | Neoplasms, Cystic, Mucinous, and Serous - surgery | Neoplasms, Cystic, Mucinous, and Serous - pathology | Risk Assessment | Humans | Middle Aged | Pancreatic Neoplasms - pathology | Pancreatic Neoplasms - surgery | Male | Tumor Burden | Carcinoma, Pancreatic Ductal - pathology | Carcinoma, Pancreatic Ductal - surgery | Pancreaticoduodenectomy - methods | Pancreatic Cyst - pathology | Pancreatic Cyst - surgery | Adult | Female | Neuroendocrine Tumors - surgery | Aged | Retrospective Studies | Pancreatectomy - methods | Practice Guidelines as Topic | Cysts | Medical colleges
Gastroenterology and Hepatology | PAPILLARY MUCINOUS NEOPLASMS | DIAGNOSIS | MALIGNANCY | PREVALENCE | GASTROENTEROLOGY & HEPATOLOGY | LESIONS | INTERNATIONAL CONSENSUS GUIDELINES | Neuroendocrine Tumors - pathology | Neoplasms, Cystic, Mucinous, and Serous - surgery | Neoplasms, Cystic, Mucinous, and Serous - pathology | Risk Assessment | Humans | Middle Aged | Pancreatic Neoplasms - pathology | Pancreatic Neoplasms - surgery | Male | Tumor Burden | Carcinoma, Pancreatic Ductal - pathology | Carcinoma, Pancreatic Ductal - surgery | Pancreaticoduodenectomy - methods | Pancreatic Cyst - pathology | Pancreatic Cyst - surgery | Adult | Female | Neuroendocrine Tumors - surgery | Aged | Retrospective Studies | Pancreatectomy - methods | Practice Guidelines as Topic | Cysts | Medical colleges
Journal Article
American Journal of Gastroenterology, ISSN 0002-9270, 09/2015, Volume 110, Issue 9, pp. 1289 - 1297
OBJECTIVES: The esophageal mucosal integrity is impaired in patients with eosinophilic esophagitis (EoE). We aimed to evaluate the effect of fluticasone...
DESMOGLEIN | MULTIPLE ALLERGIES | GASTROESOPHAGEAL-REFLUX DISEASE | DERMATITIS | FILAGGRIN | ADULTS | VALIDATION | BUDESONIDE | SKIN | GASTROENTEROLOGY & HEPATOLOGY | CHILDREN | Intestinal Mucosa - metabolism | Intestinal Mucosa - physiopathology | Prospective Studies | Eosinophils - drug effects | Follow-Up Studies | Humans | Middle Aged | Eosinophilic Esophagitis - pathology | Male | Recovery of Function | Esophagoscopy | RNA - genetics | Dose-Response Relationship, Drug | Eosinophilic Esophagitis - physiopathology | Adult | Anti-Inflammatory Agents - administration & dosage | Female | Eosinophils - pathology | Leukocyte Count | Cytokines - genetics | Real-Time Polymerase Chain Reaction | Intestinal Mucosa - ultrastructure | Gene Expression Regulation | Treatment Outcome | Electric Impedance | Deglutition - physiology | Microscopy, Electron | Biopsy | Fluticasone - administration & dosage | Eosinophilic Esophagitis - drug therapy | Cytokines - biosynthesis
DESMOGLEIN | MULTIPLE ALLERGIES | GASTROESOPHAGEAL-REFLUX DISEASE | DERMATITIS | FILAGGRIN | ADULTS | VALIDATION | BUDESONIDE | SKIN | GASTROENTEROLOGY & HEPATOLOGY | CHILDREN | Intestinal Mucosa - metabolism | Intestinal Mucosa - physiopathology | Prospective Studies | Eosinophils - drug effects | Follow-Up Studies | Humans | Middle Aged | Eosinophilic Esophagitis - pathology | Male | Recovery of Function | Esophagoscopy | RNA - genetics | Dose-Response Relationship, Drug | Eosinophilic Esophagitis - physiopathology | Adult | Anti-Inflammatory Agents - administration & dosage | Female | Eosinophils - pathology | Leukocyte Count | Cytokines - genetics | Real-Time Polymerase Chain Reaction | Intestinal Mucosa - ultrastructure | Gene Expression Regulation | Treatment Outcome | Electric Impedance | Deglutition - physiology | Microscopy, Electron | Biopsy | Fluticasone - administration & dosage | Eosinophilic Esophagitis - drug therapy | Cytokines - biosynthesis
Journal Article
Liver International, ISSN 1478-3223, 05/2019, Volume 39, Issue S1, pp. 7 - 18
Cholangiocarcinoma constitutes a heterogeneous group of malignancies that can emerge at any point of the biliary tree. Cholangiocarcinoma is classified into...
diagnosis | preneoplastic lesion | molecular profile | cholangiocarcinoma | INTRAHEPATIC CHOLANGIOCARCINOMA | BILE-DUCT | CHOLANGIOLOCELLULAR CARCINOMA | PAPILLARY MUCINOUS NEOPLASM | IN-SITU HYBRIDIZATION | BILIARY-TRACT | GROWTH-FACTOR RECEPTOR | HEPATOCELLULAR-CARCINOMA | GASTROENTEROLOGY & HEPATOLOGY | INTRADUCTAL TUBULOPAPILLARY NEOPLASMS | PRIMARY SCLEROSING CHOLANGITIS | Fibroblast growth factors | Tumor proteins | Health aspects | Analysis | Fibroblast growth factor | p53 Protein | Carcinogenesis | Neoplasms | Subgroups | Bile duct | Carcinogens | Mucin | Surgery | Tumor suppressor genes | Mutation | Diagnosis | Lesions | Isocitrate dehydrogenase | Growth factors | Cholangiocarcinoma | Fibroblast growth factor receptor 2 | Tumors | Bile
diagnosis | preneoplastic lesion | molecular profile | cholangiocarcinoma | INTRAHEPATIC CHOLANGIOCARCINOMA | BILE-DUCT | CHOLANGIOLOCELLULAR CARCINOMA | PAPILLARY MUCINOUS NEOPLASM | IN-SITU HYBRIDIZATION | BILIARY-TRACT | GROWTH-FACTOR RECEPTOR | HEPATOCELLULAR-CARCINOMA | GASTROENTEROLOGY & HEPATOLOGY | INTRADUCTAL TUBULOPAPILLARY NEOPLASMS | PRIMARY SCLEROSING CHOLANGITIS | Fibroblast growth factors | Tumor proteins | Health aspects | Analysis | Fibroblast growth factor | p53 Protein | Carcinogenesis | Neoplasms | Subgroups | Bile duct | Carcinogens | Mucin | Surgery | Tumor suppressor genes | Mutation | Diagnosis | Lesions | Isocitrate dehydrogenase | Growth factors | Cholangiocarcinoma | Fibroblast growth factor receptor 2 | Tumors | Bile
Journal Article
European radiology, ISSN 0938-7994, 2014, Volume 24, Issue 3, pp. 638 - 648
To compare the diagnostic accuracy of TE and MRE and establish cutoff levels and diagnostic strategies for both techniques, enabling selection of patients for...
Medicine & Public Health | Diagnostic Radiology | Elasticity imaging techniques | Sensitivity and specificity | Internal Medicine | Interventional Radiology | Imaging / Radiology | Hepatitis C | Ultrasound | Neuroradiology | Hepatitis B | PERFORMANCE | STIFFNESS MEASUREMENT | MAGNETIC-RESONANCE ELASTOGRAPHY | BIOPSIES | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | REPRODUCIBILITY | ACCURACY | Liver Cirrhosis - etiology | Hepatitis C, Chronic - pathology | Prospective Studies | Area Under Curve | Hepatitis C, Chronic - diagnostic imaging | Humans | Middle Aged | Magnetic Resonance Imaging - methods | Male | Hepatitis C, Chronic - complications | Hepatitis B, Chronic - diagnostic imaging | Elasticity Imaging Techniques - methods | Young Adult | Hepatitis B, Chronic - complications | Liver Cirrhosis - diagnostic imaging | Biopsy | Sensitivity and Specificity | Liver Cirrhosis - pathology | Adult | Female | ROC Curve | Hepatitis B, Chronic - pathology | Care and treatment | Comparative analysis | Liver | Fibrosis
Medicine & Public Health | Diagnostic Radiology | Elasticity imaging techniques | Sensitivity and specificity | Internal Medicine | Interventional Radiology | Imaging / Radiology | Hepatitis C | Ultrasound | Neuroradiology | Hepatitis B | PERFORMANCE | STIFFNESS MEASUREMENT | MAGNETIC-RESONANCE ELASTOGRAPHY | BIOPSIES | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | REPRODUCIBILITY | ACCURACY | Liver Cirrhosis - etiology | Hepatitis C, Chronic - pathology | Prospective Studies | Area Under Curve | Hepatitis C, Chronic - diagnostic imaging | Humans | Middle Aged | Magnetic Resonance Imaging - methods | Male | Hepatitis C, Chronic - complications | Hepatitis B, Chronic - diagnostic imaging | Elasticity Imaging Techniques - methods | Young Adult | Hepatitis B, Chronic - complications | Liver Cirrhosis - diagnostic imaging | Biopsy | Sensitivity and Specificity | Liver Cirrhosis - pathology | Adult | Female | ROC Curve | Hepatitis B, Chronic - pathology | Care and treatment | Comparative analysis | Liver | Fibrosis
Journal Article
PLoS ONE, ISSN 1932-6203, 2017, Volume 12, Issue 7, p. e0180648
Obesity frequently associates with the development of non-alcoholic fatty liver disease (NAFLD) and atherosclerosis. Chronic inflammation in white adipose...
SUPPLEMENTATION | WHITE ADIPOSE-TISSUE | BODY-WEIGHT | ACIDS | INSULIN-RESISTANCE | INFLAMMATION | MULTIDISCIPLINARY SCIENCES | STEATOHEPATITIS | DIET-INDUCED OBESITY | DEVELOPMENTAL ORIGINS | INFANT FORMULAS | Receptors, LDL - genetics | Adiposity - drug effects | Male | Caseins - administration & dosage | Animals | Diet, High-Fat | Obesity - prevention & control | Non-alcoholic Fatty Liver Disease - prevention & control | Mice | Receptors, LDL - physiology | Weight Gain | Caseins - pharmacology | Atherosclerosis - prevention & control | Medicine, Experimental | Obesity | Medical research | Models | Casein | Health aspects | Adipose tissue | Peptides | Liver | Body weight | Colony-forming cells | Arachidonic acid | Metabolic syndrome | Docosahexaenoic acid | Tissues | Low fat | Risk factors | High fat diet | Proteins | Fatty liver | Rodents | Risk assessment | Atherosclerosis | Attenuation | Lipoprotein (low density) receptors | Amyloid | Lactobacillus rhamnosus | Carbohydrates | Liver diseases | Nutrient deficiency | Ingredients | Triglycerides | Inflammation | Risk analysis | Insulin | Fatty acids | Cholesterol | Steatosis | Studies | Nutrition research | Probiotics | Diet | Food intake | Arteriosclerosis | Leptin | Collagen | Low fat diet | Weight reduction | Endocrinology
SUPPLEMENTATION | WHITE ADIPOSE-TISSUE | BODY-WEIGHT | ACIDS | INSULIN-RESISTANCE | INFLAMMATION | MULTIDISCIPLINARY SCIENCES | STEATOHEPATITIS | DIET-INDUCED OBESITY | DEVELOPMENTAL ORIGINS | INFANT FORMULAS | Receptors, LDL - genetics | Adiposity - drug effects | Male | Caseins - administration & dosage | Animals | Diet, High-Fat | Obesity - prevention & control | Non-alcoholic Fatty Liver Disease - prevention & control | Mice | Receptors, LDL - physiology | Weight Gain | Caseins - pharmacology | Atherosclerosis - prevention & control | Medicine, Experimental | Obesity | Medical research | Models | Casein | Health aspects | Adipose tissue | Peptides | Liver | Body weight | Colony-forming cells | Arachidonic acid | Metabolic syndrome | Docosahexaenoic acid | Tissues | Low fat | Risk factors | High fat diet | Proteins | Fatty liver | Rodents | Risk assessment | Atherosclerosis | Attenuation | Lipoprotein (low density) receptors | Amyloid | Lactobacillus rhamnosus | Carbohydrates | Liver diseases | Nutrient deficiency | Ingredients | Triglycerides | Inflammation | Risk analysis | Insulin | Fatty acids | Cholesterol | Steatosis | Studies | Nutrition research | Probiotics | Diet | Food intake | Arteriosclerosis | Leptin | Collagen | Low fat diet | Weight reduction | Endocrinology
Journal Article
American Journal of Gastroenterology, ISSN 0002-9270, 05/2018, Volume 113, Issue 5, pp. 765 - 772
Background: Distinguishing perihilar cholangiocarcinoma (PHC) from benign forms of sclerosing cholangitis affecting the hilar bile ducts is challenging, since...
SURGICAL COMPLICATIONS | DIAGNOSIS | SCLEROSING CHOLANGITIS | PERORAL CHOLANGIOSCOPY | IMMUNOGLOBULIN G4-ASSOCIATED CHOLANGITIS | BILIARY STRICTURES | BIOPSY | G4-RELATED DISEASE | CLASSIFICATION | GASTROENTEROLOGY & HEPATOLOGY | UTILITY | Recurrence | Liver - pathology | Follow-Up Studies | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Netherlands - epidemiology | Klatskin Tumor - diagnosis | Male | Incidence | Tertiary Healthcare - statistics & numerical data | Immunoglobulin G - immunology | Klatskin Tumor - pathology | Adult | Female | Retrospective Studies | Liver - surgery | Diagnostic Errors - statistics & numerical data | Bile Duct Neoplasms - surgery | Diagnosis, Differential | Klatskin Tumor - mortality | Survival Rate | Bile Ducts - surgery | Bile Duct Neoplasms - diagnosis | Cholangitis, Sclerosing - epidemiology | Cholangitis, Sclerosing - therapy | Cholangitis, Sclerosing - immunology | Bile Duct Neoplasms - mortality | Aged | Cholangitis, Sclerosing - diagnosis | Bile Duct Neoplasms - pathology | Klatskin Tumor - surgery | Bile Ducts - pathology
SURGICAL COMPLICATIONS | DIAGNOSIS | SCLEROSING CHOLANGITIS | PERORAL CHOLANGIOSCOPY | IMMUNOGLOBULIN G4-ASSOCIATED CHOLANGITIS | BILIARY STRICTURES | BIOPSY | G4-RELATED DISEASE | CLASSIFICATION | GASTROENTEROLOGY & HEPATOLOGY | UTILITY | Recurrence | Liver - pathology | Follow-Up Studies | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Netherlands - epidemiology | Klatskin Tumor - diagnosis | Male | Incidence | Tertiary Healthcare - statistics & numerical data | Immunoglobulin G - immunology | Klatskin Tumor - pathology | Adult | Female | Retrospective Studies | Liver - surgery | Diagnostic Errors - statistics & numerical data | Bile Duct Neoplasms - surgery | Diagnosis, Differential | Klatskin Tumor - mortality | Survival Rate | Bile Ducts - surgery | Bile Duct Neoplasms - diagnosis | Cholangitis, Sclerosing - epidemiology | Cholangitis, Sclerosing - therapy | Cholangitis, Sclerosing - immunology | Bile Duct Neoplasms - mortality | Aged | Cholangitis, Sclerosing - diagnosis | Bile Duct Neoplasms - pathology | Klatskin Tumor - surgery | Bile Ducts - pathology
Journal Article
JAMA surgery, ISSN 2168-6254, 2018, Volume 153, Issue 12, p. e183617
Importance: The recently released eighth edition of the American Joint Committee on Cancer TNM staging system for pancreatic cancer seeks to improve prognostic...
PANCREATICODUODENECTOMY | SURGERY | CLASSIFICATION | LYMPH-NODE RATIO | Online First | Online Only | Research | Original Investigation
PANCREATICODUODENECTOMY | SURGERY | CLASSIFICATION | LYMPH-NODE RATIO | Online First | Online Only | Research | Original Investigation
Journal Article